Analyst Price Target is $17.33
▲ +72.47% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for TELA Bio in the last 3 months. The average price target is $17.33, with a high forecast of $20.00 and a low forecast of $15.00. The average price target represents a 72.47% upside from the last price of $10.05.
Current Consensus is
Buy
The current consensus among 3 contributing investment analysts is to buy stock in TELA Bio.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Read More